Greg Cook is the senior director of access, policy and advocacy at Bristol Myers Squibb Australia. In a Q&A with BioPharmaDispathch, he discusses the 'access' challenge and the need for the health technology assessment review to focus on achieving the 'North Star' for patients. …
Faster patient access must be the 'North Star' for HTA review
March 22, 2023 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
Georgia Forrest
New Stories
-
The 'Dispatched' Week in Review' Podcast - 27 February
February 27, 2026 - - Podcast -
EU backs Australian-led consortium with up to $250m to advance next-generation influenza vaccines
February 26, 2026 - - Latest News -
United front forms across Asia Pacific to change the future of Pulmonary Arterial Hypertension
February 26, 2026 - - Latest News -
There are, in effect, two Pharmaceutical Benefits Schemes operating in Australia today
February 26, 2026 - - Latest News -
Reading the room on reform might mean following the Budget message
February 25, 2026 - - Latest News -
Weight-loss medicines approved in New Zealand, and recommended for funding, but pathway remains unclear
February 25, 2026 - -
Neurizon advances ALS drug program as funding, trials and global partnerships gain momentum
February 25, 2026 - - Australian Biotech